Fosun International Full Year 2024 Earnings: Misses Expectations

Fosun International (HKG:656) Full Year 2024 Results

Key Financial Results

• Revenue: CN¥192.1b (down 3.1% from FY 2023).
• Net loss: CN¥4.35b (down by 416% from CN¥1.38b profit in FY 2023).
• CN¥0.54 loss per share (down from CN¥0.17 profit in FY 2023).

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.

All figures shown in the chart above are for the trailing 12 month (TTM) period

Fosun International Revenues and Earnings Miss Expectations

Revenue missed analyst estimates by 5.6%. Earnings per share (EPS) was also behind analyst expectations.

The primary driver behind last 12 months revenue was the Happiness segment contributing a total revenue of CN¥76.7b (40% of total revenue). Notably, cost of sales worth CN¥109.8b amounted to 57% of total revenue thereby underscoring the impact on earnings. The largest operating expense was General & Administrative costs, amounting to CN¥26.4b (45% of total expenses). Over the last 12 months, the company's earnings were enhanced by non-operating gains of CN¥2.74b. Explore how 656's revenue and expenses shape its earnings.

Looking ahead, revenue is forecast to grow 8.6% p.a. on average during the next 2 years, while revenues in the Industrials industry in Hong Kong are expected to remain flat.

Performance of the Hong Kong Industrials industry.

The company's share price is broadly unchanged from a week ago.

Balance Sheet Analysis

While earnings are important, another area to consider is the balance sheet. We have a graphic representation of Fosun International's balance sheet and an in-depth analysis of the company's financial position.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.